May 30, 2017 7:59am

 

… I’m ready for some upside

The oversold are just too ripe for speculation

… Volume was low, volatility high and a new week and coming new month’s momentum will indicate stock pricing’s strength

 

Lower, maybe a mixed open expected

Companies in my headlights:   eight (8), 7 BUYS and 1 SELL

.

Critical information ahead of “our” universe’s open! I provide intelligence and analysis for short and near-term investment.

 


 

Expectation is the word for 2017 – meeting the unknowns with the soon to be exposed concerns will be the subject of investing decisions throughout this year.

 

 

Dow futures are DOWN -0.17% and NASDAQ futures are DOWN -0.13%

 

U.S. stock index futures pointed to a lower to mixed open on Tuesday as traders focused on a slew of economic data after a long holiday weekend.

European bourses were lower, as investors shifted their attention to political events going on in Europe.

Asia markets closed mixed, following a directionless session yesterday as major markets around the world were closed for various holidays.

 

Data docket: personal income and consumer spending data for April due to be released at around 8:30 a.m. ET. While S&P Case-Shiller HPI (Home Price Indices), consumer confidence and Dallas Fed manufacturing data for May are all scheduled to be reported by 10:30 a.m. ET.

 

 

The cell therapy sector closed NEGATIVE on Friday, Thursday, Wednesday and POSITIVE on Tuesday, as Monday was a holiday.

The cell therapy sector’s record after the last 5 days (of 43 covered companies):

·         Monday was Memorial Day and the U.S. markets were closed;

·         Friday closed NEGATIVE with 28 decliners, 11 advancers and 4 flats;

·         Thursday closed NEGATIVE with 24 decliners, 17 advancers and 2 flats;

·         Wednesday closed NEGATIVE with 21 decliners, 16 advancers and 6 flats;

·         Last Tuesday closed POSITIVE with 15 decliners, 25 advancers and 3 flats;

 

 

Remembering Friday’s closing bell newsletter, “for whom the bells toll - those who have fallen, not just stocks …”

  • Reiterating, “The U.S. equity market was closed on Monday due to Memorial Day.”

Tuesday will be a good day …

From the title, “Momentum measures the rate of the rise or fall in stock prices. From the standpoint of trending, momentum is a very useful indicator of strength or weakness. “

  • “History has shown us that momentum is far more useful during rising markets than during falling markets; the fact that markets rise more often than they fall is the reason for this. In other words, bull markets tend to last longer than bear markets.”

 

Momentum will help you recognize that the sector is NOT dead yet; while distinct trend lines rise like the phoenix from the ashes!

 

 

What did I see on Friday, stocks closed mixed on Friday ahead of the Memorial Day holiday weekend and digested key economic data.

I think the cell therapy sector has been feeling the pain of the lack of news and is preparing to figure things out. But I do think “our” universe is going to make a significant move higher as a new month is about to begin.

The DOW closed DOWN -0.01% (-2.67) as the NASDAQ also closed UP +0.08% (+4.94) as the CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market, traded near 9.8 …

 

The U.S. equity market was closed on Monday due to Memorial Day, which led to subdued trading volumes on Friday

 

The count - gainers: look at the differences in the spreads and advance/decline lines – look at how the numbers define volatility.

The highs of the decliners I believe have peaked while gainers need some room to grow expodentially …

·         Friday’s decliners ranged from -0.50% <BCLI> to -11.41% <ISCO> in 28 equities;

·         Thursday’s decliners ranged from -0.55% <CLLS> to -8.46% <MESO> in 24 equities;

·         Wednesday’s decliners ranged from -0.03% <OPXA> to -4.46% <CAPR> in 21 equities;

·         Last Tuesday’s decliners ranged from -0.24% <BCLI> to -8.54% <ISCO> in 15 equities;

While gainers…

·         Friday’s gainers ranged from +0.25% <BSTG> to +5.63% <VCEL> in 11 equities;

·         Thursday’s gainers ranged from +0.06% <BLUE> to +4.79% <CAPR> in 17 equities;

·         Wednesday’s gainers ranged from +0.16% <ONCE> to +8.46% <NWBO> in 16 equities;

·         Last Tuesday’s gainers ranged from +0.51% <OSIR> to +13.62% <BSTG> in 25 equities;

 

 

You’ve made it to the office, turned on the monitor, having just gotten your coffee and it hits you - what could be today’s trades? 

Watch list:

  • The iShares Nasdaq Biotechnology (IBB) closed down -0.79% on Friday, and NOT indicating a in Tuesday’s pre-market;
  • The SPDR S&P Biotech ETF (XBI) closed Friday down -1.80% and is NOT indicating  in Tuesday pre-market;
  • The Health Care Select Sector SPDR ETF (XLV) closed down -0.18% Friday, and is NOT indicating n Tuesday’s pre-open;
  • The iShares Russell 2000 (IWM) closed down -0.03% on Friday, and is indicating a NEGATIVE -0.50% in Tuesday’s pre-open

 

 

Companies in my headlights – I am not lazy in defining any upside or downside, I just don’t see any input other than momentum.

.............  The issue: OVERSOLD …

Bellicum Pharmaceuticals (BLCM) closed down -$0.36 to $11.83 after Thursday’s $12.19 (-$0.29). The aftermarket indication is a positive +$0.1172 or +0.99%. Oversold – Maintaining BUY;

bluebird bio (BLUE) closed down -$1.10 to $78.70 after Thursday’s $79.80 (+$0.05) following Wednesday’s $79.75 (-$0.60). The aftermarket indication is a POSITIVE +$0.913 or +1.16% - BUY;

Juno Therapeutics (JUNO) closed down -$2.22 to $23.20 after Thursday’s $25.52 (+$0.19). The aftermarket indication is a POSITIVE +$0.47 or +2.02% - BUY;

Kite Pharma (KITE) closed down -$1.80 to $73.11 after Thursday’s $74.91(+$3.25). The aftermarket indication is a POSITIVE +$0.70 or +0.96% - BUY;

Organovo (ONVO) closed up +$0.09 to $2.94 following Thursday’s flat at $2.85. The aftermarket indication is a POSITIVE +$0.01 or +0.34% - BUY;

Regenxbio (RGNX) closed down -$0.65 to $18.00 following Thursday’s $18.65 (-$0.20) after Wednesday’s $18.85 (+$0.25). The aftermarket indication is a POSITIVE +$0.1042 or +0.58% - BUY;

Sangamo Therapeutics (SGMO) closed down -$0.55 to $7.25.  The aftermarket indication is a NEGATIVE -$0.105 to $1.44% - SELL;

Spark Therapeutics (ONCE) closed down -$2.63 to $52.99 after Thursday’s $55.62 (+$0.33) following Wednesday’s $55.28 (+$0.08). The aftermarket indication is a POSITIVE +$0.87 or +1.64% - BUY;

 

 

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.

Henry’s comments are for informational purposes only and are not a substitute for personalized advice. Consult your advisor about what is best for you.